AGIO
Agios Pharmaceuticals, Inc.
31.80$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 674.9% | 285.6% | 597.0% | 703.5% | 642.0% | 788.0% | 892.8% | 214.6% | 4.6% | 2.3% | 1.1% | 1.2% | 1.5% | 0.8% | 0.6% | 1.8% | 1.8% | 2.2% | 11.8% | 12.6% | – | 11,132,576.7% | 631.4% | 93.3% | 142.5% | 111.1% | 88.3% | 83.0% | 8.6% | 28.0% | 24.1% | 35.8% | 8.7% | 11.7% | 27.1% | 23.8% | 23.7% | 15.8% | 12.9% | 6.7% | 12.1% | |
| -574.9% | -185.6% | -497.0% | -603.5% | -542.0% | -688.0% | -792.8% | -114.6% | 95.4% | 97.7% | 98.9% | 98.8% | 98.5% | 99.2% | 99.4% | 98.2% | 98.2% | 97.8% | -11.8% | -12.6% | – | -11,132,576.7% | -531.4% | 6.7% | -42.5% | -11.1% | 11.7% | 17.0% | 91.4% | 72.0% | 75.9% | 64.2% | 91.3% | 88.3% | 72.9% | 76.2% | 76.3% | 84.2% | 87.1% | 93.3% | 87.9% | |
| 674.9% | 285.6% | 597.0% | 703.5% | 642.0% | 788.0% | 892.8% | 214.6% | 543.2% | 312.6% | 316.2% | 409.6% | 390.7% | 299.8% | 104.8% | 243.4% | 258.0% | 217.4% | 133.3% | 159.7% | – | 171,690,412.9% | 8,130.4% | 1,294.0% | 1,791.4% | 1,589.0% | 1,168.0% | 999.5% | 1,106.1% | 1,071.2% | 821.5% | 880.0% | 808.3% | 771.8% | 819.0% | 728.1% | 663.2% | 434.7% | 384.6% | 225.2% | 358.7% | |
| 131.9% | 67.9% | 141.1% | 142.2% | 153.7% | 231.8% | 280.2% | 65.9% | 204.7% | 170.5% | 105.2% | 123.5% | 126.9% | 98.3% | 44.2% | 96.3% | 100.4% | 90.3% | 19.6% | 78.2% | – | 76,136,199.0% | 3,787.9% | 506.3% | 828.3% | 760.3% | 505.7% | 453.1% | 349.0% | 497.0% | 378.7% | 412.5% | 429.9% | 481.8% | 475.9% | 368.3% | 320.5% | 258.5% | 232.8% | 115.2% | 196.0% | |
| 806.9% | 353.5% | 738.1% | 845.6% | 795.7% | 1,019.8% | 1,173.0% | 280.5% | 747.9% | 418.7% | 421.4% | 533.1% | 517.6% | 398.1% | 149.0% | 339.7% | 358.4% | 307.7% | 208.5% | 231.7% | – | 242,011,591.4% | 11,625.5% | 1,755.9% | 2,548.2% | 2,289.8% | 1,627.2% | 1,413.0% | 1,455.1% | 1,568.2% | 1,200.2% | 1,292.4% | 1,238.2% | 1,253.6% | 1,294.9% | 1,096.3% | 983.7% | 693.1% | 617.4% | 340.4% | 554.7% | |
| -706.9% | -253.5% | -638.1% | -745.6% | -695.7% | -919.8% | -1,073.0% | -180.5% | -652.5% | -321.0% | -322.5% | -434.2% | -419.1% | -298.9% | -49.6% | -241.5% | -260.3% | -209.9% | -220.3% | -244.3% | – | -253,144,168.1% | -12,156.9% | -1,749.2% | -2,590.7% | -2,301.0% | -1,615.5% | -1,396.0% | -1,363.7% | -1,496.2% | -1,124.3% | -1,228.3% | -1,146.9% | -1,165.3% | -1,222.0% | -1,020.1% | -907.4% | -608.9% | -530.3% | -247.1% | -466.8% | |
| 7.5% | 4.1% | 8.4% | 13.4% | 16.6% | 18.8% | 36.4% | 10.4% | 29.6% | 15.2% | 14.6% | 15.2% | 11.1% | 10.1% | 3.4% | 5.5% | 28.1% | 13.7% | 0.8% | 0.2% | – | 801,738.7% | 83.4% | 32.1% | 108.6% | 150.5% | 171.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -699.3% | -249.4% | -629.7% | -732.3% | -679.1% | -901.0% | -1,036.6% | -170.1% | -622.9% | -305.8% | -307.9% | -419.0% | -408.0% | -288.8% | -96.6% | -213.5% | -224.9% | -221.7% | -219.5% | -221.7% | – | -238,068,099.5% | -11,391.1% | -1,644.7% | -2,325.0% | 847.5% | -1,444.4% | -1,248.6% | -1,234.3% | -1,350.7% | -995.8% | -1,115.7% | 11,167.3% | -982.3% | -1,023.3% | -899.4% | -803.1% | -546.2% | -477.7% | -225.1% | -419.3% | |
| 0.0% | -7.6% | 0.0% | 0.0% | 0.0% | -16.9% | -19.7% | 0.0% | 0.0% | -6.4% | – | – | – | -5.5% | – | 4.7% | 3.2% | -4.3% | -31.1% | 4.1% | – | 801,738.7% | -765.7% | -80.6% | -265.7% | -3,148.4% | -171.1% | -149.9% | -135.1% | 19.1% | 15.9% | – | 592.6% | -82.7% | – | – | – | -5.1% | – | – | – | |
| -699.3% | -249.4% | -629.7% | -732.3% | -679.1% | -901.0% | -1,036.6% | -170.1% | -622.9% | -305.8% | -307.9% | -419.0% | -408.0% | -288.8% | -46.2% | -242.3% | -285.2% | -221.7% | -285.5% | -223.4% | – | -228,512,436.6% | -11,391.1% | -1,644.7% | -2,325.0% | 847.5% | -1,444.4% | -1,248.6% | -1,234.3% | -1,350.7% | -995.8% | -1,115.7% | 10,574.7% | -899.6% | -1,023.3% | -899.4% | -803.1% | -541.1% | -477.7% | -225.1% | -418.2% | |
| -690.9% | -245.9% | -622.9% | -731.8% | -681.5% | -902.9% | -1,053.3% | -176.2% | -640.6% | -314.7% | -315.9% | -411.3% | -400.0% | -293.4% | -43.4% | -230.3% | -250.1% | -202.0% | -207.6% | -208.9% | – | -226,935,522.8% | -10,800.5% | -1,559.2% | -2,197.2% | 949.0% | -1,366.0% | -1,182.1% | -1,212.3% | -1,330.9% | -979.4% | -1,097.2% | 11,182.3% | -969.5% | -1,008.6% | -889.3% | -792.4% | -539.8% | -471.2% | -244.1% | -423.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.